Epiretinal Cell Proliferation

Epiretinal cell proliferation refers to the growth of extra cells on the very surface of the retina, especially over the central area called the macula. When these cells grow, they can make a thin sheet or membrane that lies on top of the retina. This membrane is called an epiretinal membrane (ERM), sometimes known as a “macular pucker” or “cellophane maculopathy” because it can look like a thin plastic wrap covering the retina. The membrane may contract over time, pulling on the retina, which distorts vision. This whole process — migration, multiplication, and transformation of various cell types (like glial cells, retinal pigment epithelial cells, hyalocytes, and fibroblasts) onto the retinal surface — is what we mean by epiretinal cell proliferation. PMC PubMed EyeWiki

There is a special related but distinct form called epiretinal proliferation (EP), often seen with lamellar macular holes or some full-thickness macular holes. EP appears different under imaging: it is usually more homogeneous and adherent, and its cell makeup and behavior are not identical to the classic ERM. EP is sometimes called thick or dense ERM in different contexts, but researchers now recognize it as a separate entity with its own features. PMCPMCSpringerLinkEurope PMC

The vitreomacular interface is where the gel-like vitreous inside the eye touches the macula. Changes here, especially when the vitreous pulls away (called posterior vitreous detachment), can open tiny defects in the innermost retinal layer (the internal limiting membrane) and allow cells to move to the surface, start changing into fibrotic-type cells (like myofibroblasts), and lay down the membrane. The process of glial cells transforming, and the interaction with other cells like hyalocytes, leads to the contracted fibrocellular tissue. ScienceDirectEyeWiki

Epiretinal cell proliferation refers to the growth of a thin layer of cells and fibrous tissue on the surface of the retina, especially over the macula (the central part of the retina responsible for sharp vision). When these cells—often glial cells, fibroblasts, retinal pigment epithelial cells, or myofibroblasts—multiply and lay down membrane-like tissue on the inner retinal surface, they form what is commonly called an epiretinal membrane (ERM) or, in some distinct patterns, epiretinal proliferation (ERP). This membrane can contract over time, creating mechanical traction, puckering, or distortion of the underlying retinal architecture, leading to vision changes. The process is typically slow and may be idiopathic (no clear cause) or secondary to other retinal insults such as inflammation, retinal tears, diabetic retinopathy, retinal vascular disease, prior eye surgery, or trauma.NCBI EyeWiki

---

Types of Epiretinal Cell Proliferation / Membranes

1. Idiopathic Epiretinal Membrane (ERM):
This type happens without a clear prior eye disease. It most often occurs in older adults and is linked to age-related changes in the vitreous and small breaks in the internal limiting membrane that allow glial or other retinal cells to migrate and form a membrane. Idiopathic means no known primary cause. PubMedScienceDirect

2. Secondary Epiretinal Membrane:
This grows because of another eye condition, injury, or surgery. The underlying event triggers inflammation, cell migration, or scarring that leads to membrane formation. Common triggers include retinal vascular diseases, surgery (like cataract or prior retinal surgery), inflammation (uveitis), retinal tears or detachment, and trauma. PMCWiley Online Library

3. Epiretinal Proliferation Associated with Lamellar Macular Hole (LMH):
This type of proliferation is seen around lamellar macular holes. It looks different from classic ERM on imaging and is thought to come from a different balance of cell types, often being less contractile but more adherent, and is associated with partial-thickness defects of the macula. ScienceDirectEurope PMCSpringerLink

4. Epiretinal Proliferation in Full-Thickness Macular Holes:
Although less common, EP can be seen at the edge of full-thickness macular holes, and it can affect healing or surgical outcomes. Nature

5. Tractional Epiretinal Membranes:
These membranes cause pulling or traction on the retina, leading to visible wrinkling or distortion that can change vision. Tractional effect is a functional descriptor and may overlap with idiopathic or secondary types when contraction leads to mechanical deformation. AAO Journal

---

Causes of Epiretinal Cell Proliferation

1. Aging and Posterior Vitreous Detachment (PVD):
   As people age, the vitreous gel shrinks and separates from the retina. This separation can tear or weaken the internal limiting membrane, letting cells reach the surface and start forming an ERM. This is the most common mechanism behind idiopathic ERM. ScienceDirectEyeWiki

2. Retinal Tear or Break:
   A tear in the retina can cause inflammation and allow migration of cells. The healing response can include proliferation on the surface. PubMed

3. Retinal Detachment (and its repair):
   Detachment itself and surgical repair provoke cell movement and scarring; both can lead to secondary ERM formation. PMC

4. Proliferative Vitreoretinopathy (PVR):
   This aggressive scarring process after retinal breaks or detachment involves growth of membranes including on the retinal surface and can include epiretinal proliferation. PMC

5. Diabetic Retinopathy (especially Proliferative):
   Long-term diabetes damages retinal vessels; abnormal new vessels and inflammation stimulate fibrocellular proliferation leading to ERM, sometimes with traction. SpringerLink

6. Retinal Vein Occlusion (central or branch):
   Blockage of veins causes swelling and ischemia, leading to secondary inflammation and cell proliferation at the macular surface. PMC

7. Hypertensive Retinopathy or Retinal Vascular Disease:
   High blood pressure and other vascular conditions damage the retina, promoting secondary membrane formation through ischemic and inflammatory pathways. PMC

8. Uveitis (Intraocular Inflammation):
   Inflammation inside the eye releases cytokines and attracts cells that can migrate and proliferate on the retinal surface forming membranes. SpringerLink

9. Eye Surgery (e.g., Cataract Surgery, Vitrectomy):
   Any intraocular surgery disrupts normal barriers and may trigger healing responses that include ERM formation. PubMedWiley Online Library

10. Ocular Trauma:
    Physical injury to the eye causes inflammation and disruption to retinal layers, leading to secondary epiretinal proliferation. PMC

11. Macular Hole Formation:
    Partial or full-thickness holes in the macula alter the local environment and can be associated with epiretinal proliferation, especially in lamellar macular holes. ScienceDirectEurope PMC

12. Persistent Cortical Vitreous (Incomplete PVD):
    Residual vitreous fibers remaining attached can promote traction and micro-injury leading to membrane formation. EyeWiki

13. Retinal Hemorrhage (from various causes):
    Bleeding in the retina brings inflammatory cells and growth factors that can lead to fibrosis and membrane formation. PMC

14. Infectious Retinitis (e.g., Cytomegalovirus, Toxoplasmosis):
    Infection causes inflammation and tissue damage, triggering proliferative healing responses on the retinal surface. SpringerLink

15. Autoimmune Eye Disorders:
    Conditions such as sarcoidosis or Behçet’s can cause recurrent inflammation and increase the risk of ERM. SpringerLink

16. Vitreous Hemorrhage:
    Blood in the vitreous may contribute to inflammatory and fibrotic responses, encouraging epiretinal cell growth. PMC

17. Retinal Ischemia (from any cause):
    Low oxygen in retinal tissue upregulates pro-fibrotic signals, promoting membrane formation. PMC

18. Previous Laser Treatment (e.g., Photocoagulation):
    Laser can cause localized inflammation and healing that secondarily leads to membranes. PMC

19. Vitreoretinal Interface Abnormalities (traction syndromes):
    Chronic traction from vitreomacular adhesion or anomalous PVD creates microdamage and stimulates cell proliferation. AAO JournalEyeWiki

20. Idiopathic Fibrocellular Activation (unknown triggers):
    Sometimes the membrane grows without any identifiable preceding event or disease, reflecting intrinsic changes in retinal healing or cell behavior with age. PubMed

---

Symptoms of Epiretinal Cell Proliferation (ERM / EP)

1. Blurry Central Vision:
   The most common complaint; the membrane distorts the retinal surface so central vision becomes unclear. Dove Medical PressAAO Journal

2. Metamorphopsia (Vision Distortion):
   Straight lines appear wavy or bent because of the pulling effect of the membrane on the macula. Patients often notice this first when reading or looking at grids. Dove Medical PressAAO Journal

3. Micropsia or Macropsia:
   Objects may appear smaller (micropsia) or larger (macropsia) due to changes in how the retina maps images after distortion. Dove Medical PressAAO Journal

4. Difficulty Reading Fine Print:
   Because the central vision is affected and lines look crooked, focusing on small letters becomes hard. Dove Medical PressAAO Journal

5. Monocular Double Vision (Diplopia):
   Some people perceive double images in one eye because the membrane causes irregular light bending on the retina. AAO Journal

6. Reduced Contrast Sensitivity:
   Colors and details may seem washed out or harder to distinguish; the membrane interferes with fine visual processing. Annals of Eye Science

7. Central Scotoma (Small Blind Spot):
   A small area in the center of vision may seem missing or dim because the underlying retina is distorted. Dove Medical PressBioMed Central

8. Perception of a “Film” or “Veil” Over Vision:
   Some describe a faint covering or cloudiness over their central sight, from the membrane’s effect. American Society of Retina Specialists

9. Image Displacement:
   Objects may seem shifted from their true location, another form of distortion due to mechanical traction. AAO Journal

10. Slowly Worsening Vision over Months:
    Most ERMs progress gradually, with symptoms increasing slowly, unless abrupt traction or associated disease accelerates change. PubMed

11. Difficulty with Depth Perception (in Severe Cases):
    Distortion of central vision can trick the brain about spatial relationships, affecting depth judgment. AAO Journal

12. Sensitivity to Light Changes:
    Fluctuations in lighting may make distortions more noticeable or uncomfortable, reflecting central retinal stress. (Inferred from macular functional disturbances.) Annals of Eye Science

13. Color Vision Changes:
    Colors may look less bright or slightly altered if the macular architecture is disrupted. Annals of Eye Science

14. Reading Fatigue or Eye Strain:
    Because the eye works harder to interpret distorted images, prolonged visual tasks cause tiredness. AAO Journal

15. Subjective Visual Fluctuation:
    Vision may feel variable day-to-day, especially if traction changes slightly, or coexisting macular swelling occurs. Dove Medical PressBioMed Central

---

Diagnostic Tests

A. Physical Examination

1. Visual Acuity Measurement (e.g., Snellen or LogMAR):
   This checks how well a person can see at distance or near. It quantifies the amount of central vision loss caused by the membrane. Dove Medical Press

2. Pupillary Reflex Testing (including afferent pupillary defect):
   Assesses the nerve pathways and can help rule out other optic nerve or retinal dysfunctions that might accompany or mimic ERM symptoms. Medscape

3. Intraocular Pressure Check:
   Though not directly diagnostic for ERM, elevated pressure can coexist or cause other retinal changes; it’s part of full eye health assessment. Medscape

4. Dilated Fundus Examination with Slit-Lamp and Indirect Ophthalmoscopy:
   The eye doctor uses drops to widen the pupil and a special lens to look directly at the macula. The membrane may be seen as a shiny surface or retinal wrinkle. This exam helps visually grade traction and assess retinal anatomy. Dove Medical PressAAO Journal

B. Manual / Functional Tests

5. Amsler Grid Test:
   A simple square grid the patient looks at to detect metamorphopsia or missing areas in central vision. Wavy or broken lines suggest macular distortion from ERM. Dove Medical PressSpringerLink

6. Metamorphopsia Quantification (e.g., M-Charts):
   More precise tools than the Amsler grid, M-charts measure the degree of line bending or distortion and can track change over time. SpringerLink

7. Contrast Sensitivity Testing (e.g., Pelli-Robson Chart):
   Tests how well someone can see differences between shades; ERM can reduce contrast sensitivity even when standard acuity is relatively preserved. Annals of Eye Science

8. Microperimetry:
   Maps light sensitivity across the macula while correlating to structural imaging; it shows how the membrane distorts functional sensitivity. NatureScienceDirect

C. Laboratory and Pathological Tests

9. Blood Sugar / HbA1c (Diabetes Screening):
   High blood sugar damages retinal vessels and is a common underlying cause of secondary ERM, so diabetes evaluation is important. SpringerLink

10. Inflammatory Markers (ESR, CRP):
    Elevated markers may suggest active inflammation or systemic disease contributing to uveitis and secondary membranes. SpringerLink

11. Infectious Workup (e.g., Syphilis Serology, TB Testing):
    Certain infections can cause uveitis or retinitis, which then lead to ERM. Syphilis and tuberculosis are common infectious causes in inflammatory retinal disease workups. SpringerLink

12. Autoimmune Panel (e.g., ANA, HLA-B27):
    Autoimmune diseases can inflame the eye (uveitis) and result in secondary membrane formation; identifying them guides therapy. SpringerLink

13. Histopathology of Peeled Membrane:
    If surgery is done, the removed membrane can be examined under the microscope. Special stains and immunohistochemistry (for glial fibrillary acidic protein, collagen, etc.) identify the cell types and confirm the diagnosis. IOVS

D. Electrodiagnostic Tests

14. Multifocal Electroretinography (mfERG):
    Measures electrical responses from many small retinal regions simultaneously. It detects localized macular dysfunction caused by the membrane and correlates with visual acuity and OCT changes. PMCBioMed CentralPubMed

15. Full-field Electroretinography (ffERG):
    Records the global electrical response of the retina; while less sensitive for small central changes, it helps rule out widespread retinal disease. Aetna

16. Visual Evoked Potentials (VEP), including Pattern-Reversal VEP:
    Measures how well visual signals travel from the eyes to the brain. ERM can delay and reduce VEP signals, reflecting macular distortion and its effect on visual pathway timing. PubMedPubMedWiley Online Library

E. Imaging Tests

17. Optical Coherence Tomography (OCT):
    The most important imaging test. It gives a cross-sectional picture of the retina, showing the membrane, retinal thickness, presence of traction, and related changes like pseudoholes or macular edema. OCT can distinguish epiretinal proliferation from conventional ERM based on reflectivity and adherence patterns. Dove Medical PressSpringerLinkPLOS

18. Color Fundus Photography:
    Photographs the back of the eye, documenting the appearance of the membrane, retinal vessel distortion, and tracking changes over time. Dove Medical Press

19. Fluorescein Angiography:
    Injects dye into a vein to visualize blood flow in the retina. It helps assess associated vascular disease, leakage, or capillary changes that may relate to secondary ERM causes. Dove Medical Press

20. B-scan Ocular Ultrasound:
    Used when the view of the retina is blocked (e.g., by cataract or vitreous hemorrhage) to detect the presence of membranes, detachments, or other structural problems. Dove Medical Press

Non-Pharmacological Treatments

1. Watchful Waiting / Observation
   Many epiretinal membranes are mild and cause little to no vision loss. Watching with regular eye exams and repeat OCTs is the first approach when symptoms are minimal; this avoids unnecessary intervention. The purpose is to monitor progression and intervene only if vision deteriorates. Mechanism: no active treatment—relies on the natural slow course of some membranes.Healthline

2. Regular Optical Coherence Tomography (OCT) Monitoring
   High-resolution OCT is used periodically to track any changes in membrane thickness, retinal distortion, or worsening traction. Purpose: early detection of progression. Mechanism: noninvasive imaging guiding decision-making.AAO Journal

3. Visual Rehabilitation / Low Vision Aids
   When vision is affected, specialized magnifiers, contrast-enhancing glasses, and adaptive lighting help maximize remaining vision. The purpose is improving daily function despite distortion. Mechanism: optical compensation and neural adaptation. (General low-vision practice; extrapolated to ERM impact on central vision.)Healthline

4. Amsler Grid Self-Monitoring
   Patients use an Amsler grid at home to detect new or worsening central distortion (metamorphopsia). Purpose: empower early reporting of changes. Mechanism: simple visual test sensitive to macular changes.AAO Journal

5. Control of Systemic Vascular Risk Factors
   Managing diabetes, high blood pressure, and high cholesterol reduces the risk of secondary retinal diseases that can trigger membrane formation. Purpose: prevention of secondary causes. Mechanism: limiting retinal ischemia and inflammation.Venice Retina

6. Smoking Cessation
   Smoking increases oxidative stress and microvascular damage in the eye. Quitting lowers the risk of retinal degeneration and may slow progression. Purpose: protect retinal health. Mechanism: reducing free radical damage and improving microcirculation.SpringerLink

7. Anti-Inflammatory Diet (Rich in Antioxidants)
   Eating foods high in lutein, zeaxanthin, omega-3s, vitamins C/E, zinc, and other antioxidants supports retinal cellular health and may reduce low-grade inflammation. Purpose: support retina, possibly slow fibrotic change. Mechanism: scavenging reactive oxygen species and modulating inflammatory pathways.PMCPMCSpringerLink

8. Weight Management / Healthy Lifestyle
   Obesity can worsen systemic inflammation; maintaining healthy weight supports overall vascular and ocular health. Purpose: reduce comorbid contributions. Mechanism: lowering systemic pro-inflammatory mediators.SpringerLink

9. UV Protection / Sunglasses
   Limiting excessive ultraviolet and blue-light exposure may reduce cumulative retinal oxidative damage. Purpose: long-term retinal preservation. Mechanism: filtering high-energy light that generates reactive oxygen species.SpringerLink

10. Improved Glycemic Control in Diabetics
    Strict blood sugar control reduces the risk of diabetic retinopathy, which can lead to secondary ERM. Purpose: prevent one of the triggers. Mechanism: lowering glucose-induced vascular and inflammatory injury.Venice Retina

11. Prompt Treatment of Ocular Inflammation
    Early therapy for uveitis or other inflammatory eye disease reduces the chance of proliferative membranes forming. Purpose: reduce secondary membrane formation. Mechanism: suppressing cytokine-driven cellular proliferation.American Society of Retina Specialists

12. Avoiding Ocular Trauma
    Eye injuries can incite inflammatory and healing responses that promote membrane formation. Purpose: primary prevention. Mechanism: preventing disruption of retinal surface and inflammatory cascades.American Society of Retina Specialists

13. Careful Management and Follow-up After Retinal Surgery
    After detachment repair or other vitreoretinal surgery, careful follow-up can catch early ERM formation. Purpose: early intervention if needed. Mechanism: surveillance to limit sequelae of post-surgical proliferation.PMCNature

14. Use of Contrast and Lighting Modifications in Daily Life
    Adjusting fonts, screen brightness, and room lighting reduces functional impact of visual distortion. Purpose: symptom mitigation. Mechanism: optimizing visual input to compensate for central distortion. (Standard low vision guidance.)Healthline

15. Patient Education and Shared Decision-Making
    Explaining the natural history, symptoms to watch for, and treatment thresholds increases adherence and timely presentation. Purpose: improve outcomes via informed follow-up. Mechanism: empowerment. (Best practice in chronic eye disease.)Healthline

16. Eye Movement / Oculomotor Training
    In some low-vision rehabilitation programs, training to use different retinal loci can help patients adapt to distortion. Purpose: neuroadaptation to altered central vision. Mechanism: developing preferred retinal loci outside the distorted zone.Healthline

17. Reducing Digital Eye Strain
    Using regular breaks and optimizing screen ergonomics reduces fatigue that exaggerates perception of visual distortion. Purpose: comfort and functional adaptation. Mechanism: minimizing accommodative stress.Healthline

18. Management of Coexisting Cataract (when appropriate)
    If a cataract is also present and limiting vision, cataract removal can improve overall visual function even if ERM remains. Purpose: maximize visual acuity. Mechanism: removing optical opacities to reduce combined visual impairment.Healthline

19. Avoiding Unproven “Eye Drops” or Home Remedies
    Some non-evidence-based treatments claim benefit; avoiding these prevents delay in proper care. Purpose: reduce harm. Mechanism: sticking to validated surveillance and intervention. (General medical caution.)BioMed Central

20. Psychological Support / Counseling for Visual Anxiety
    Vision changes can cause stress; addressing mental health improves coping. Purpose: holistic care. Mechanism: reducing anxiety-related functional decline. (Standard in chronic vision impairment.)Healthline

---

 Drug Treatments

Important note: There is no widely accepted oral or topical drug that dissolves an epiretinal membrane. Medical treatments are generally adjunctive, aimed at reducing inflammation, modulating scar formation (especially in proliferative vitreoretinopathy), or managing associated macular edema. Surgery remains the definitive treatment for vision-threatening traction.NatureScienceDirect

1. Intravitreal Triamcinolone Acetonide (Corticosteroid)

   • Class: Corticosteroid

   • Dosage/Timing: Typically 2 mg intravitreal injection; may be given at the time of vitrectomy or for associated inflammation/edema.

   • Purpose: Reduce inflammation and cellular proliferation that can worsen membrane-related traction or PVR (when present).

   • Mechanism: Suppresses cytokines, inhibits fibroblast proliferation, stabilizes blood-retinal barrier.

   • Side Effects: Elevated intraocular pressure, cataract formation, risk of infection.PMC

2. Dexamethasone Intravitreal Implant (e.g., Ozurdex)

   • Class: Corticosteroid implant

   • Dosage/Timing: 0.7 mg biodegradable implant released over months; used for associated macular edema or inflammation.

   • Purpose: Similar to triamcinolone, provide sustained anti-inflammatory effect with fewer injections.

   • Mechanism: Glucocorticoid receptor-mediated downregulation of inflammatory mediators.

   • Side Effects: Increased eye pressure, cataract progression.ScienceDirect

3. Anti-VEGF Agents (Bevacizumab / Ranibizumab / Aflibercept)

   • Class: Vascular endothelial growth factor inhibitors

   • Dosage/Timing: Intravitreal injections per standard retinal edema protocols (often monthly initially).

   • Purpose: Treat associated macular edema or vascular leakage that may coexist and worsen vision.

   • Mechanism: Block VEGF to reduce vascular permeability and neovascular-related inflammation.

   • Side Effects: Rare endophthalmitis, transient increased intraocular pressure.

   • Evidence Note: Not primary therapy for ERM but used when edema confounds visual symptoms.HealthlineScienceDirect

4. 5-Fluorouracil (5-FU) with Low Molecular Weight Heparin (LMWH)

   • Class: Antimetabolite + anticoagulant (used in PVR prophylaxis)

   • Dosage/Timing: Intraoperative infusion in selected retinal detachment/PVR cases.

   • Purpose: Reduce postoperative proliferative vitreoretinopathy that can lead to epiretinal scarring.

   • Mechanism: 5-FU inhibits DNA synthesis in proliferating cells; heparin may reduce cellular adhesion.

   • Side Effects: Potential toxicity if misdosed; limited to surgical setting.ScienceDirect

5. Methotrexate (Intravitreal, Experimental in PVR)

   • Class: Antimetabolite / immunosuppressant

   • Dosage/Timing: Low-dose intravitreal injections in trial settings for PVR prevention.

   • Purpose: Limit fibrocellular proliferation of membranes.

   • Mechanism: Inhibits dihydrofolate reductase, reducing DNA synthesis in proliferative cells.

   • Side Effects: Retinal toxicity at high doses; experimental use only.Nature

6. 13-cis-Retinoic Acid (Isotretinoin derivative studied in PVR)

   • Class: Retinoid

   • Dosage/Timing: Studied in combination with other agents perioperatively for scar modulation.

   • Purpose: Potentially reduce scar tissue formation after retinal surgery.

   • Mechanism: Modulates gene expression affecting cell differentiation and proliferation.

   • Side Effects: Systemic toxicity if misused; not standard for ERM.ScienceDirect

7. Adjunctive Anti-inflammatory Eye Drops (NSAID or Steroid Drops)

   • Class: Topical NSAIDs or steroids

   • Dosage: Typical postoperative regimens to control surface inflammation after surgery.

   • Purpose: Reduce low-grade inflammation that might aggravate retinal traction postoperatively.

   • Mechanism: Block prostaglandin synthesis or inflammatory cytokines.

   • Side Effects: Ocular surface irritation, elevated intraocular pressure (with steroids). (Supportive perioperative use.)Nature

8. Transforming Growth Factor-Beta (TGF-β) Modulators (Experimental)

   • Class: Anti-fibrotic research agents

   • Purpose: Target fibrotic signaling in membrane formation.

   • Mechanism: TGF-β is a key driver of fibrosis; blocking its signaling may reduce membrane contraction.

   • Evidence: Preclinical; under investigation for PVR and fibrotic ocular disease.Nature

9. Matrix Metalloproteinase Modulators (Experimental)

   • Class: Enzyme activity regulators

   • Purpose: Influence extracellular matrix remodeling in membrane development.

   • Mechanism: MMPs degrade matrix; modulating their activity might change membrane progression.

   • Evidence: Mostly preclinical.Nature

10. Anti-Inflammatory Systemic Agents When Underlying Disease Present (e.g., systemic steroids for uveitis)

    • Class: Systemic corticosteroids or immunomodulators

    • Purpose: Treat underlying inflammatory cause to reduce secondary membrane formation.

    • Mechanism: Broad immunosuppression reducing cytokines and cellular migration.

    • Side Effects: Systemic risks (weight gain, glucose elevation, infection).American Society of Retina Specialists

---

Dietary Molecular Supplements

1. Lutein

   • Dosage: 10 mg daily (common in clinical trials).

   • Function: Antioxidant and macular pigment enhancer; supports central retinal health.

   • Mechanism: Filters blue light, scavenges free radicals, protects photoreceptors and inner retina from oxidative stress.PMCIOVS

2. Zeaxanthin

   • Dosage: 2 mg to 10 mg daily in combination with lutein.

   • Function: Works with lutein to strengthen macular pigment density.

   • Mechanism: Blue light filtering and direct antioxidant protection, reducing phototoxic stress.Verywell HealthMDPI

3. Omega-3 Fatty Acids (DHA/EPA)

   • Dosage: 250–1000 mg combined DHA/EPA daily depending on formulation.

   • Function: Anti-inflammatory support and cell membrane integrity for retinal neurons.

   • Mechanism: Modulates inflammatory eicosanoid pathways, supports photoreceptor survival, and may protect against secondary retinal damage.PMCPMCMacular Degeneration Association

4. Vitamin C

   • Dosage: 500–1000 mg daily (as part of AREDS-type combinations).

   • Function: General antioxidant protecting retinal cells.

   • Mechanism: Neutralizes reactive oxygen species, maintains extracellular matrix integrity.PMC

5. Vitamin E

   • Dosage: 400 IU in combination formulas.

   • Function: Lipid-soluble antioxidant guarding photoreceptor membranes.

   • Mechanism: Prevents lipid peroxidation in retinal cell membranes.PMC

6. Zinc

   • Dosage: 25–80 mg daily (with copper to prevent deficiency).

   • Function: Cofactor in many antioxidant enzymes; supports retinal metabolism.

   • Mechanism: Stabilizes cell membranes, assists in antioxidant defense through metallothionein induction.PMC

7. Copper

   • Dosage: 2 mg daily when supplementing with zinc.

   • Function: Prevents zinc-induced copper deficiency; involved in antioxidant enzymes.

   • Mechanism: Cofactor for cytochrome c oxidase and superoxide dismutase.PMC

8. Astaxanthin

   • Dosage: 4–12 mg daily in supplements.

   • Function: Potent antioxidant with neuroprotective potential for retina.

   • Mechanism: Crosses blood-retinal barrier, quenching free radicals and reducing inflammation. (Emerging evidence).naturaleyecare.com

9. Alpha-Lipoic Acid

   • Dosage: 300–600 mg daily.

   • Function: Regenerates other antioxidants (like vitamins C and E), supports mitochondrial health.

   • Mechanism: Scavenges reactive oxygen species and regenerates oxidized antioxidants, supporting retinal cell survival under stress.SpringerLink

10. N-Acetylcysteine (NAC)

    • Dosage: 600–1200 mg daily (oral) in general antioxidant use.

    • Function: Precursor to glutathione, the body’s master antioxidant.

    • Mechanism: Boosts intracellular glutathione, reducing oxidative damage that can contribute to fibrotic responses.SpringerLink

Note: Most supplement evidence is extrapolated from macular degeneration and general retinal health; direct evidence for preventing or reversing epiretinal membrane is limited, but they support an environment less prone to oxidative/inflammatory worsening.SpringerLink

---

Regenerative / Stem Cell Approaches

1. Retinal Pigment Epithelium (RPE) Derived from Induced Pluripotent Stem Cells (iPSC)

   • Dosage/Delivery: Surgically implanted cell patches beneath the retina (clinical trial protocols vary).

   • Function: Replace damaged support cells, potentially improving retinal health and reducing secondary stress that might exacerbate membranes.

   • Mechanism: Differentiated RPE cells integrate and support photoreceptor nutrition and waste removal.

   • Evidence: Early-phase trials show safety and potential for vision improvement in degenerative diseases; applicability to ERM is theoretical as improving underlying retinal health may reduce traction consequences.PMCPMC

2. Mesenchymal Stem Cells (MSCs) Intravitreal Injection

   • Dosage: Experimental dosing varies; delivered via injection in controlled studies.

   • Function: Provide neuroprotective and anti-inflammatory paracrine effects.

   • Mechanism: Secrete trophic factors that reduce apoptosis, modulate inflammation, and support retinal cell survival.

   • Evidence: Safety signals in early studies; efficacy still under investigation.BioMed Central

3. Encapsulated Cell Therapy Delivering Neurotrophic Factors (e.g., CNTF – NT-501 implant)

   • Dosage: Implanted device releasing ciliary neurotrophic factor over months.

   • Function: Sustain delivery of protective molecules to retina.

   • Mechanism: CNTF supports neuron survival and may stabilize retinal structure, potentially mitigating secondary degeneration from traction.

   • Evidence: Studied in retinal degenerative conditions; direct ERM data limited.PMC

4. Retinal Progenitor Cell Transplantation

   • Dosage: Surgical placement in subretinal or epiretinal space under trial settings.

   • Function: Replace or support damaged retinal neurons.

   • Mechanism: Differentiate into retinal cell types; release supportive growth factors.

   • Evidence: Preclinical and early clinical work indicates potential neuroregeneration.PMC

5. Human Embryonic Stem Cell–Derived Retinal Cells

   • Dosage: Implanted sheets or cell suspensions in clinical protocols.

   • Function: Replace degenerating retinal tissue to improve structural integrity.

   • Mechanism: Provide healthy retinal epithelial support and reduce secondary stress on macula.

   • Evidence: Early successes in AMD raise hope for broader retinal applications, although not standard for ERM.The Guardian

6. Retinal Cell Scaffold + Stem Cell Constructs (Structured Delivery)

   • Dosage: Engineered scaffolds carrying stem-cell-derived retinal pigment cells or photoreceptors.

   • Function: Improve cell survival and appropriate anatomical placement.

   • Mechanism: Physical support combining stem cell therapy with architectural guidance to repopulate damaged retinal areas.

   • Evidence: Experimental work suggests improved outcomes when cells are delivered with structure.WIRED

Caution: All regenerative/stem cell therapies for ERM are experimental. Many unregulated clinics offer “stem cell” injections with unproven benefit and risk of serious harm; only participate in FDA/ethically approved clinical trials.BioMed Central

---

Surgeries (Procedures and Why Done)

1. Pars Plana Vitrectomy with Epiretinal Membrane Peeling

   • Procedure: Small-gauge vitrectomy to remove the vitreous gel followed by peeling of the epiretinal membrane using microforceps.

   • Why Done: To relieve traction on the macula, flatten the retinal surface, and improve or stabilize vision that is distorted or reduced.

   • Details: Often the internal limiting membrane (ILM) is also peeled to reduce recurrence. Dyes like brilliant blue or indocyanine green help visualize membranes.AAO Journal

2. Combined Vitrectomy and Cataract Surgery (Phacovitrectomy)

   • Procedure: Simultaneous removal of cataract and ERM during the same surgery.

   • Why Done: Many patients with ERM are older and have concurrent cataracts; combining surgeries reduces overall recovery time and addresses multiple causes of vision loss.Healthline

3. Internal Limiting Membrane (ILM) Peeling

   • Procedure: In addition to ERM peeling, the thin ILM layer is removed to decrease the chance that membrane cells re-proliferate.

   • Why Done: To lower recurrence rates and improve long-term anatomical outcomes.AAO Journal

4. Use of Intraoperative Adjuncts (Dyes, Tamponade as Needed)

   • Procedure: Application of staining dyes for better visualization and, rarely, use of gas tamponade if concurrent macular hole or fluid dynamics require it.

   • Why Done: Improves precision of peeling and optimizes retinal reattachment/flattening in complex cases.AAO Journal

5. Reoperation for Recurrent or Persistent Membrane

   • Procedure: Repeat vitrectomy and membrane peeling if vision declines again due to recurrence.

   • Why Done: Address new traction or regrowth when the first surgery did not achieve stable improvement.

   • Details: May include adjunctive approaches like extended ILM peel.AAO Journal

---

Preventive Strategies

1. Early Detection through Regular Eye Exams
   Catching vitreomacular interface abnormalities early allows monitoring before severe membrane formation.Retina Today

2. Prompt Management of Vitreomacular Traction or Adhesion
   Treating abnormal adhesion early may prevent the development of membranes and associated traction.Retina Today

3. Control of Systemic Diseases (Diabetes, Hypertension)
   Reduces secondary retinal injury that can seed membrane formation.Venice Retina

4. Avoidance of Ocular Inflammation / Quick Treatment of Uveitis
   Inflammation promotes cell migration and proliferation on the retinal surface.American Society of Retina Specialists

5. Smoking Cessation
   Lowers oxidative stress burden and vascular compromise in the retina.SpringerLink

6. Protective Eyewear to Prevent Trauma
   Shielding the eye from injuries that could initiate membrane-forming healing responses.American Society of Retina Specialists

7. Optimizing Nutrition for Retinal Health
   Including antioxidants and omega-3s to create a less pro-fibrotic retinal environment.SpringerLink

8. Careful Surgical Technique in Retinal Surgeries
   Minimizing postoperative inflammation and the risk of PVR reduces secondary membrane risks.Nature

9. Avoidance of Unnecessary Intraocular Procedures
   Only perform surgeries when indicated, as any intraocular manipulation can theoretically trigger proliferation.American Society of Retina Specialists

10. Patient Education on Early Symptoms
    Knowing what to look for (e.g., distortion) leads to timely presentation before irreversible changes.AAO Journal

---

When to See a Doctor

• You notice wavy or distorted central vision (metamorphopsia).Healthline

• Blurred central vision that doesn’t improve with blinking or rest.Healthline

• Micropsia or macropsia (objects appearing smaller or larger).Healthline

• Sudden change in vision after eye surgery, trauma, or inflammation.American Society of Retina Specialists

• Persistent difficulty reading fine print or recognizing faces.Healthline

• New or worsening central scotoma (dark spot).AAO Journal

• Abnormalities detected on self-testing (Amsler grid).AAO Journal

• If your ophthalmologist notes progression on OCT.AAO Journal

• If you have risk factors (diabetes, prior retinal surgery) and develop any visual symptoms.American Society of Retina Specialists

• Unexplained visual changes that interfere with daily activities. (General guidance.)Healthline

---

What to Eat and What to Avoid

What to Eat (Supports Retinal Health):
Eat foods rich in lutein and zeaxanthin (dark leafy greens like spinach and kale, eggs), omega-3 fatty acids (fatty fish such as salmon or plant-based algae oil), antioxidants (citrus, berries, nuts for vitamin C/E), zinc (legumes, seeds), and carotenoids (colorful vegetables). These nutrients help maintain the retinal environment, lower oxidative stress, and support cellular resilience.HealthPMCPMC

What to Avoid:
Limit excessive processed sugars and refined carbohydrates (which worsen diabetes), high saturated and trans fats (vascular risk), smoking (oxidative and vascular damage), and excessive alcohol (nutritional and inflammatory effects). Avoid unproven “eye supplements” from dubious sources. Maintaining balanced hydration and avoiding nutrient deficiencies is also important.Venice RetinaSpringerLink

---

Frequently Asked Questions (FAQs)

1. Can an epiretinal membrane go away by itself?
   Sometimes mild membranes remain stable and cause no symptoms; they do not “vanish,” but may not worsen, so observation is appropriate.Healthline

2. What causes epiretinal cell proliferation?
   Causes include aging changes, prior eye surgery, inflammation, trauma, diabetic retinopathy, retinal vascular events, and vitreomacular interface abnormalities.American Society of Retina Specialists

3. What are the first symptoms?
   Early signs are visual distortion (wavy lines), blurred central vision, difficulty reading, or seeing straight lines as bent.Healthline

4. How is it diagnosed?
   Diagnosis relies on an eye exam, OCT imaging to visualize the membrane and retinal distortion, and functional testing like visual acuity and Amsler grid.AAO Journal

5. Do I need surgery immediately?
   Not always. If vision is good and symptoms mild, the usual approach is to watch. Surgery is recommended if vision is significantly affected or worsening.Healthline

6. What does surgery involve?
   Vitrectomy with membrane peeling (often including ILM peeling) to release traction. It is typically done under local or general anesthesia.AAO Journal

7. Is the surgery successful?
   Many patients experience improved vision or stabilization; the degree depends on how long the membrane has been present and underlying retinal health. Recurrence is reduced by ILM peeling.AAO Journal

8. Can the membrane come back after peeling?
   Yes, but peeling the internal limiting membrane during surgery lowers the risk.AAO Journal

9. Are there medicines that can remove the membrane?
   No approved medication dissolves ERM. Some drugs (like steroids or experimental anti-fibrotics) may help related inflammation or scarring but are not replacements for surgery if traction is severe.NatureScienceDirect

10. Can supplements help?
    Supplements like lutein, zeaxanthin, and omega-3s support overall retinal health; direct reversal of membranes is unlikely, but they may help create a protective internal environment.PMCPMC

11. Is there any risk in waiting?
    If vision is stable and symptoms minor, waiting with monitoring is safe. Delay becomes risky if traction increases and causes permanent photoreceptor damage.Healthline

12. What if I have both a cataract and ERM?
    Combined surgery can be planned to address both, often yielding better visual results than staged procedures.Healthline

13. Are stem cell treatments available for this?
    Stem cell approaches are experimental and not standard for ERM. They are mostly studied in degenerative retinal diseases and do not yet have proven benefit for membrane removal. Participation should only occur in approved clinical trials.BioMed CentralWIRED

14. What happens if I ignore it?
    Mild cases may remain stable, but progressive traction can cause lasting vision distortion or loss if not addressed when indicated.Healthline

15. How often should I get checked?
    Frequency depends on severity; stable minimal membranes can be reviewed every 6–12 months, while progressive symptoms warrant more frequent monitoring (every 3–4 months or sooner).AAO Journal

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 03, 2025.